NCT00611572View on ClinicalTrials.gov

GABA-glutamate Interactions and Psychosis

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

October 2, 2018

Study Completion Date

October 2, 2018

Conditions
Cognitive Dysfunction
Interventions
DRUG

iomazenil

Given as IV infusion

DRUG

iomazenil

saline IV infusion

Trial Locations (1)

06516

VHA Connecticut, West Haven

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Yale University

OTHER

NCT00611572 - GABA-glutamate Interactions and Psychosis | Biotech Hunter | Biotech Hunter